Recombinant factor VIIa in massive postpartum haemorrhage

被引：25
作者：
Karalapillai, D. [1 ]
Popham, P. [1 ]
机构：
[1] Royal Hosp Women, Dept Anaesthesia, Carlton, Vic, Australia
来源：
INTERNATIONAL JOURNAL OF OBSTETRIC ANESTHESIA | 2007年 / 16卷 / 01期
关键词：
postpartum haemorrhage; factor VIIa; anaesthesia; obstetrics;
D O I：
10.1016/j.ijoa.2006.09.001
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
Massive postpartum haemorrhage is a major cause of maternal and fetal morbidity and mortality. Management mainstays include transfusion therapy, uterotonic agents and surgery. The "off label" use of recombinant activated factor VII appears to have an evolving role in the management of massive postpartum haemorrhage refractory to conventional treatments. The current literature is reviewed. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码：29 / 34
页数：6
相关论文
共 47 条
  • [1] Recombinant factor VIIa for life-threatening post-partum haemorrhage
    Ahonen, J
    Jokela, R
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 2005, 94 (05) : 592 - 595
  • [2] Aledort LM, 2000, THROMB HAEMOSTASIS, V84, P522
  • [3] Comparative thrombotic event incidence after infusion of recombinant factor VIIa versus factor VII inhibitor bypass activity
    Aledort, LM
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (10) : 1700 - 1708
  • [4] BANNINGER H, 1994, BIOCHEM J, V298, P157
  • [5] Recombinant activated factor VII (rFVIIa/NovoSeven®) in intractable haemorrhage:: use of a clinical scoring system to predict outcome
    Biss, TT
    Hanley, JP
    [J]. VOX SANGUINIS, 2006, 90 (01) : 45 - 52
  • [6] FIBRIN IN HUMAN PLASMA - GEL ARCHITECTURES GOVERNED BY RATE AND NATURE OF FIBRINOGEN ACTIVATION
    BLOMBACK, B
    CARLSSON, K
    FATAH, K
    HESSEL, B
    PROCYK, R
    [J]. THROMBOSIS RESEARCH, 1994, 75 (05) : 521 - 538
  • [7] Prolonged treatment of massive postpartum haemorrhage with recombinant factor VIIa: case report and review of the literature
    Boehlen, F
    Morales, MA
    Fontana, P
    Ricou, B
    Irion, O
    de Moerloose, P
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2004, 111 (03) : 284 - 287
  • [8] Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: Two parallel randomized, placebo-controlled, double-blind clinical trials
    Boffard, KD
    Riou, B
    Warren, B
    Choong, PIT
    Rizoli, S
    Rossaint, R
    Axelsen, M
    Kluger, Y
    [J]. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2005, 59 (01): : 8 - 16
  • [9] Successful treatment of life-threatening postpartum hemorrhage with recombinant activated factor VII
    Bouwmeester, FW
    Jonkhoff, AR
    Verheijen, RHM
    van Geijn, HP
    [J]. OBSTETRICS AND GYNECOLOGY, 2003, 101 (06) : 1174 - 1176
  • [10] 'Last-ditch' use of recombinant factor VIIa in patients with massive haemorrhage is ineffective
    Clark, AD
    Gordon, WC
    Walker, ID
    Tait, RC
    [J]. VOX SANGUINIS, 2004, 86 (02) : 120 - 124
12345